BioDelivery Sciences International, Inc.
| Nasdaq: BDSI
BioDelivery Sciences International, Inc. is a specialty pharmaceutical company that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties. It is focusing on developing products to meet unmet patient needs in the areas of pain management and addiction. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC.